Table 2.

Depicting the suggested treatment regime for infective endocarditis in the general population as per guidelines published in American Family Physician.

Treatment regimen for Infectious endocarditis in general population
Empiric therapy	(i) Vancomycin or ampicillin/sulbactam with an aminoglycoside (ii) Add rifampin in patients with prosthetic valves
Penicillin susceptible viridans Streptococcus or Streptococcus bovis (S. bovis)	(i) Penicillin G or ceftriaxone for 4 weeks Or  (ii) Penicillin G plus gentamycin for 2 weeks Or  (iii) Ceftriaxone plus gentamycin for 2 weeks Or  (iv) Vancomycin for 4 weeks
Relatively penicillin resistant viridans Streptococcus or S. bovis	(i) Penicillin G or ceftriaxone for 4 weeks, plus gentamycin for 2 weeks Or (ii) Vancomycin for 4 weeks
Penicillin-resistant viridans Streptococcus or S. bovis	(i) Ampicillin plus gentamycin for 4–6 weeks Or (ii) Penicillin G plus gentamycin for 4–6 weeks Or (iii) Vancomycin for 6 weeks
Oxacillin- susceptible staphylococci	(i) Nafcillin or oxacillin for 6 weeks, plus gentamycin for 3–5 days (optional) Or (ii) Cefazolin for 6 weeks plus gentamycin for 3–5 days (optional)
Oxacillin-resistant staphylococci	(i) Vancomycin for 6 weeks